TWO SIGMA SECURITIES, LLC - NLS PHARMACEUTICS LTD ownership

Back to all holdings Add to watchlist

NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 10 filers reported holding NLS PHARMACEUTICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
TWO SIGMA SECURITIES, LLC ownership history of NLS PHARMACEUTICS LTD
ValueSharesWeighting
Q2 2023$40,806
+271.0%
37,096
+110.4%
0.00%–
Q3 2022$11,000
-56.0%
17,630
+73.9%
0.00%
-100.0%
Q3 2021$25,000–10,140–0.00%–
 Download
Other shareholders
NLS PHARMACEUTICS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
BVF INC/IL 5,747,126$3,970,6890.11%
Affinity Asset Advisors, LLC 200,455$140,3190.04%
J. Goldman & Co LP 254,601$178,2210.01%
BANK OF AMERICA CORP /DE/ 90$630.00%
WELLS FARGO & COMPANY/MN 56,549$39,5840.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 14,362$9,9220.00%
Renaissance Technologies 21,100$150.00%
View complete list of NLS PHARMACEUTICS LTD shareholders